CannIntelligence open content

US hemp production totals for 2021 are released in new report from the USDA

Written by Freddie Dawson | 11th March 2022

Hemp production in the US in 2021 totalled $824m in value – the vast majority of which came from hemp grown for flowers, according to a report from the United States Department of Agriculture (USDA)...

Is investing in cannabis in 2022 a smart bet or a ‘dead-money scenario’?

Written by Lorraine Mullaney | 9th March 2022

Last month CBD-Intel reported that the Dermapharm Holding bought Canopy Growth’s Cannabinoid Compound Company (C3) for €80m, a huge loss for Canopy, and one of the biggest cannabis acquisitions in Europe at the time. But what makes...

More medical applications for cannabinoids being explored

Written by Lorraine Mullaney | 4th March 2022

Scientists around the world are starting to look even further afield for potential uses of cannabis in medical applications, such as treating the symptoms of long Covid-19, Alzheimer’s-related agitation, and to alleviate the pain resulting...

NORML releases delta-8 THC info that’s both misleading and potentially divisive

Written by Freddie Dawson | 3rd March 2022

One of the most prestigious cannabis legalisation lobbying groups has come out with a disappointing – but not surprising – strong line against hemp-derived delta-8 THC products ...

Mississippi medical cannabis bill finally becomes law

Written by CannIntelligence | 25th February 2022

Mississippi has finally signed a medical cannabis bill into law after a long and often arduous...

The changing face of endorsements as they get more mainstream – and whiter

Written by CannIntelligence | 17th February 2022

What was once the purview of more “controversial” or “alternative” names has now become the territory of mainstream celebrities designed to appeal to a wider – and whiter – audience ...

Market and regulatory outlook: future
cannabis strategies in Europe 2022

Written by Tim Phillips | 10th February 2022

This presentation on the market and regulatory outlook for consumer cannabis products in Europe was given by CBD-Intel’s managing director Tim Phillips ...

Only in California: the fresh vape that’s cannabis and nothing but the cannabis

Written by Aidan Semmens | 9th February 2022

The latest offering from the company that first devised the Juul e-cigarette looks sure to be a new Californian craze – a new vaping pod “made solely from pure cannabis” ...

Costa Rica’s president promises to get cannabis legalisation done despite veto

Written by CannIntelligence | 7th February 2022

Costa Rican president Carlos Alvarado, who has supported the legalisation of cannabis throughout his administration, has partially vetoed a bill that would have legalised medicinal cannabis and industrial hemp ...

Export expert outlines post-Brexit tips for moving goods into the UK or Europe

Written by Lorraine Mullaney | 2nd February 2022

Andy Hooper, CEO of Global E-Commerce Experts, provides tips for companies wishing to export into Europe. He'll expand on this in a talk at White Label World Expo in London on 2nd and 3rd March...

Will UK FSA at last publish an updated list of validated novel food applications?

Written by Freddie Dawson | 2nd February 2022

Don't hold your breath, but rumours are swirling that the UK Food Standards Agency (FSA) will soon publish an updated, completed list of CBD novel food applications that have been fully validated ...

Despite industry investment, the future remains cloudy for cannabinoid drinks

Written by Lorraine Mullaney | 20th January 2022

Covid has significantly increased consumer interest in health and wellness, with food and drink formulations that create innovative solutions for “mental and emotional wellbeing” becoming a 2021 trend ...

Leading judge hears industry arguments against French ban on hemp flower sales

Written by CannIntelligence | 17th January 2022

The first public hearing has been held on the industry challenge against the French government decree confirming the continuation of the ban on selling hemp flower as an end-product ...

How US Democrats’ cannabis reform plans ran aground despite promises

Written by Lorraine Mullaney | 12th January 2022

After early promise, no cannabis-focused legislation has yet made it onto president Joe Biden’s desk for signing. So why is that? ...

Insurance rule ‘a billion-dollar shot in the arm’ for Colombian cannabis market

Written by CannIntelligence | 11th January 2022

Colombian insurance providers must now cover the cost of medical cannabis prescriptions, a move that could represent a “billion-dollar shift” in the market – and perhaps lay down a marker for other countries ...

Colombian insurance policy shows real intent to lead on cannabinoids

Written by Freddie Dawson | 6th January 2022

Colombia has joined a select few countries now demanding mandatory coverage of medical cannabis by health insurance providers ...

Rival bills aim to establish a pathway to the US market for ingestible CBD

Written by CannIntelligence | 3rd January 2022

US representatives have introduced a bill into the House aiming to push the US Food and Drug Administration (FDA) to regulate CBD in food and drinks ...